Keylicon Biosciences Secures Exclusive Rights to Modified Self-Amplifying RNA Technology
- Posted on January 14, 2025
- By Google News
- 1 Views
Keylicon Biosciences Secures Exclusive Rights to Modified Self-Amplifying RNA Technology
BOSTON, Jan. 14, 2025 /PRNewswire/ -- Keylicon Biosciences is pleased to announce its exclusive rights to a groundbreaking next-generation RNA technology developed at Boston University. This innovation enables protein expression
